Proteomic study of HPV-positive head and neck cancers: Preliminary results

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Descamps, Géraldine ^a   Wattiez, Ruddy ^a   Saussez, Sven ^a  

^a UNIVERSITY OF MONS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DIENOYL COENZYME A REDUCTASE (NADPH); ACETYL COENZYME A ACETYLTRANSFERASE; ALPHA2 INTEGRIN; ANXA4 PROTEIN; CELLUBREVIN; CHAPERONIN CONTAINING TCP1; CHOLINE PHOSPHATE CYTIDYLYLTRANSFERASE; CHOLINE PHOSPHATE CYTIDYLYLTRANSFERASE A; ELONGATION FACTOR 1ALPHA; ENOLASE; FUMARATE HYDRATASE; GLUTATHIONE REDUCTASE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN BETA 1; HIGH MOBILITY GROUP N1 PROTEIN; ISOCITRATE DEHYDROGENASE 1; LAMIN A; LAMIN C; MARCKS PROTEIN; PEROXIREDOXIN 6; PHOSPHOGLUCONATE DEHYDROGENASE; PHOSPHOGLYCERATE KINASE; PLECTIN; PROSTATE STEM CELL ANTIGEN; PROTEIN MSH2; S PHASE KINASE ASSOCIATED PROTEIN; TAR DNA BINDING PROTEIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 185; TUMOR PROTEIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CARCINOMA CELL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HYPOPHARYNX CARCINOMA; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MALE; MOUTH CARCINOMA; OROPHARYNX CARCINOMA; PAPILLOMAVIRUS INFECTION; PHARYNX CARCINOMA; PROTEIN EXPRESSION; PROTEOMICS; TANDEM MASS SPECTROMETRY; UPREGULATION; VERY ELDERLY; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; HEAD AND NECK TUMOR; MIDDLE AGED; MOUTH TUMOR; PAPILLOMA VIRUS; PATHOLOGY; PROGNOSIS; RISK FACTOR; SQUAMOUS CELL CARCINOMA; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM PROTEINS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; PROTEOMICS; RISK FACTORS;

EID: 84897845902     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/430906     Document Type: Article

References (41)

1. Filleul O., Preillon J., Crompot E., Lechien J., Saussez S., Incidence of head and neck cancers in Belgium: comparison with worldwide and French data. Bulletin du Cancer 2011 98 10 1173 1183 2-s2.0-80755130582 10.1684/bdc.2011.1456
2. Ankola A. A., Smith R. V., Burk R. D., Prystowsky M. B., Sarta C., Schlecht N. F., Comorbidity, human papillomavirus infection and head and neck cancer survival in an ethnically diverse population. Oral Oncology 2013 49 9 911 917
3. Ragin C. C. R., Taioli E., Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. International Journal of Cancer 2007 121 8 1813 1820 2-s2.0-34548680936 10.1002/ijc.22851 (Pubitemid 47417302)
4. Duray A., Descamps G., Decaestecker C., Remmelink M., Sirtaine N., Lechien J., Ernoux-Neufcoeur P., Bletard N., Somja J., Depuydt C. E., Delvenne P., Saussez S., Human papillomavirus DNA strongly correlates with a poorer prognosis in oral cavity carcinoma. Laryngoscope 2012 122 7 1558 1565 2-s2.0-84859936200 10.1002/lary.23298
5. Hansson B. G., Rosenquist K., Antonsson A., Wennerberg J., Schildt E.-B., Bladström A., Andersson G., Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Oto-Laryngologica 2005 125 12 1337 1344 2-s2.0-28444485665 10.1080/00016480510043945 (Pubitemid 41722001)
6. Rosenquist K., Wennerberg J., Annertz K., Schildt E.-B., Hansson B. G., Bladström A., Andersson G., Recurrence in patients with oral and oropharyngeal squamous cell carcinoma: human papillomavirus and other risk factors. Acta Oto-Laryngologica 2007 127 9 980 987 2-s2.0-34548303929 10.1080/00016480601110162 (Pubitemid 47345810)
7. Morshed K., Association between human papillomavirus infection and laryngeal squamous cell carcinoma. Journal of Medical Virology 2010 82 6 1017 1023 2-s2.0-77953533526 10.1002/jmv.21749
8. Ernoux-Neufcoeur P., Arafa M., Decaestecker C., Duray A., Remmelink M., Leroy X., Herfs M., Somja J., Depuydt C. E., Delvenne P., Saussez S., Combined analysis of HPV DNA, p16, p21 and p53 to predict prognosis in patients with stage IV hypopharyngeal carcinoma. Journal of Cancer Research and Clinical Oncology 2011 137 1 173 181 2-s2.0-78751611207 10.1007/s00432-010-0871-2
9. Duray A., Descamps G., Arafa M., Decaestecker C., Remmelink M., Sirtaine N., Ernoux-Neufcoeur P., Mutijima E., Somja J., Depuydt C. E., Delvenne P., Saussez S., High incidence of high-risk HPV in benign and malignant lesions of the larynx. International Journal of Oncology 2011 39 1 51 59 2-s2.0-79956044565 10.3892/ijo.2011.1031
10. Gillison M. L., Koch W. M., Capone R. B., Spafford M., Westra W. H., Wu L., Zahurak M. L., Daniel R. W., Viglione M., Symer D. E., Shah K. V., Sidransky D., Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. Journal of the National Cancer Institute 2000 92 9 709 720 2-s2.0-0034600339 (Pubitemid 30365531)
11. Hafkamp H. C., Manni J. J., Haesevoets A., Voogd A. C., Schepers M., Bot F. J., Hopman A. H. N., Ramaekers F. C. S., Speel E.-J. M., Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. International Journal of Cancer 2008 122 12 2656 2664 2-s2.0-43049097865 10.1002/ijc.23458 (Pubitemid 351631366)
12. Lo W. Y., Lai C. C., Hua C. H., Tsai M. H., Huang S.-Y., Tsai C.-H., Tsai F.-J., S100A8 is identified as a biomarker of HPV18-infected oral squamous cell carcinomas by suppression subtraction hybridization, clinical proteomics analysis, and immunohistochemistry staining. Journal of Proteome Research 2007 6 6 2143 2151 2-s2.0-34250853563 10.1021/pr060551+ (Pubitemid 46985100)
13. Ott H. W., Lindner H., Sarg B., Mueller-Holzner E., Abendstein B., Bergant A., Fessler S., Schwaerzler P., Zeimet A., Marth C., Illmensee K., Calgranulins in cystic fluid and serum from patients with ovarian carcinomas. Cancer Research 2003 63 21 7507 7514 2-s2.0-10744219895 (Pubitemid 37413495)
14. Melle C., Ernst G., Winkler R., Schimmel B., Klussmann J. P., Claus Wittekindt C. W., Orlando Guntinas-Lichius O. G.-L., Von Eggeling F., Proteomic analysis of human papillomavirus-related oral squamous cell carcinoma: identification of thioredoxin and epidermal-fatty acid binding protein as upregulated protein markers in microdissected tumor tissue. Proteomics 2009 9 8 2193 2201 2-s2.0-65349134094 10.1002/pmic.200800882
15. Marur S., Forastiere A. A., Head and neck cancer: changing epidemiology, diagnosis, and treatment. Mayo Clinic Proceedings 2008 83 4 489 501 2-s2.0-42149129398 10.4065/83.4.489 (Pubitemid 351536473)
16. Koch W. M., Clinical features of HPV-related head and neck squamous cell carcinoma: presentation and work-up. Otolaryngologic Clinics of North America 2012 45 4 779 793
17. Westra W. H., Taube J. M., Poeta M. L., Begum S., Sidransky D., Koch W. M., Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck. Clinical Cancer Research 2008 15 2 366 369 2-s2.0-38949118675 10.1158/1078-0432.CCR-07-1402 (Pubitemid 351226102)
18. Chung C. H., Gillison M. L., Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications. Clinical Cancer Research 2009 15 22 6758 6762 2-s2.0-72549102589 10.1158/1078-0432.CCR-09-0784
19. Bernier J., Domenge C., Ozsahin M., Matuszewska K., Lefèbvre J.-L., Greiner R. H., Giralt J., Maingon P., Rolland F., Bolla M., Cognetti F., Bourhis J., Kirkpatrick A., Van Glabbeke M., Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. The New England Journal of Medicine 2004 350 19 1945 1952 2-s2.0-2342592623 10.1056/NEJMoa032641 (Pubitemid 38580197)
20. Lang K., Menzin J., Earle C. C., Jacobson J., Hsu M. A., The economic cost of squamous cell cancer of the head and neck: findings from linked SEER-medicare data. Archives of Otolaryngology, Head & Neck Surgery 2004 130 11 1269 1275 2-s2.0-8844221168 10.1001/archotol.130.11.1269 (Pubitemid 39532259)
21. Ye H., Wang A., Lee B. S., Yu T., Sheng S., Peng T., Hu S., Crowe D. L., Zhou X., Proteomic based identification of manganese superoxide dismutase 2 (SOD2) as a metastasis marker for oral squamous cell carcinoma. Cancer Genomics and Proteomics 2008 5 2 85 94 2-s2.0-43149088252
22. Reiter R. E., Gu Z., Watabe T., Thomas G., Szigeti K., Davis E., Wahl M., Nisitani S., Yamashiro J., Le Beau M. M., Loda M., Witte O. N., Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proceedings of the National Academy of Sciences of the United States of America 1998 95 4 1735 1740 2-s2.0-13144250150 10.1073/pnas.95.4.1735 (Pubitemid 28103463)
23. Bahrenberg G., Brauers A., Joost H. G., Jakse G., Reduced expression of PSCA, a member of the LY-6 family of cell surface antigens, in bladder, esophagus, and stomach tumors. Biochemical and Biophysical Research Communications 2000 275 3 783 788 2-s2.0-0034618581 10.1006/bbrc.2000.3393
24. Gu Z., Thomas G., Yamashiro J., Shintaku I. P., Dorey F., Raitano A., Witte O. N., Said J. W., Loda M., Reiter R. E., Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer. Oncogene 2000 19 10 1288 1296 2-s2.0-0034594917 (Pubitemid 30160621)
25. de Nooij-van Dalen A. G., van Dongen G. A., Smeets S. J., Characterization of the human Ly-6 antigens, the newly annotated member Ly-6K included, as molecular markers for head-and-neck squamous cell carcinoma. International Journal of Cancer 2003 103 6 768 774 2-s2.0-0037352493 10.1002/ijc.10903 (Pubitemid 36110233)
26. Kawaguchi T., Sho M., Tojo T., Yamato I., Nomi T., Hotta K., Hamada K., Suzaki Y., Sugiura S., Kushibe K., Nakajima Y., Taniguchi S., Clinical significance of prostate stem cell antigen expression in non-small cell lung cancer. Japanese Journal of Clinical Oncology 2010 40 4 319 326 2-s2.0-77951251437 10.1093/jjco/hyp181
27. Saeki N., Gu J., Yoshida T., Wu X., Prostate stem cell antigen: a Jekyll and Hyde molecule? Clinical Cancer Research 2010 16 14 3533 3538 2-s2.0-77954748206 10.1158/1078-0432.CCR-09-3169
28. Stroncek D. F., Caruccio L., Bettinotti M., CD177: a member of the Ly-6 gene superfamily involved with neutrophil proliferation and polycythemia vera. Journal of Translational Medicine 2004 2 1, article 8 2-s2.0-4344575870 10.1186/1479-5876-2-8 (Pubitemid 39130363)
29. + T cells by activating integrin-dependent adhesion pathways. Proceedings of the National Academy of Sciences of the United States of America 1997 94 13 6898 6903 2-s2.0-0030979628 10.1073/pnas.94.13.6898 (Pubitemid 27281962)
30. Lee S. K., Su B., Maher S. E., Bothwell A. L. M., Ly-6A is required for T cell receptor expression and protein tyrosine kinase fyn activity. The EMBO Journal 1994 13 9 2167 2176 2-s2.0-0028336617 (Pubitemid 24139730)
31. Zhao Z., Ma W., Zeng G., Qi D., Ou L., Liang Y., Small interference RNA-mediated silencing of prostate stem cell antigen attenuates growth, reduces migration and invasion of human prostate cancer PC-3M cells. Urologic Oncology 2013 31 3 343 351
32. Ono H., Hiraoka N., Lee Y. S., Woo S. M., Lee W. J., Choi I. J., Saito A., Yanagihara K., Kanai Y., Ohnami S., Chiwaki F., Sasaki H., Sakamoto H., Yoshida T., Saeki N., Prostate stem cell antigen, a presumable organ-dependent tumor suppressor gene, is down-regulated in gallbladder carcinogenesis. Genes Chromosomes and Cancer 2012 51 1 30 41 2-s2.0-80455176960 10.1002/gcc.20928
33. Gross S. R., Kinzy T. G., Translation elongation factor 1A is essential for regulation of the actin cytoskeleton and cell morphology. Nature Structural and Molecular Biology 2005 12 9 772 778 2-s2.0-26944487335 10.1038/nsmb979 (Pubitemid 43086251)
34. Duttaroy A., Bourbeau D., Wang X. L., Wang E., Apoptosis rate can be accelerated or decelerated by overexpression or reduction of the level of elongation factor-1 α Experimental Cell Research 1998 238 1 168 176 2-s2.0-0031845912 10.1006/excr.1997.3819 (Pubitemid 28366139)
35. van Goietsenoven G., Hutton J., Becker J. P., Lallemand B., Robert F., Lefranc F., Pirker C., Vandenbussche G., Van Antwerpen P., Evidente A., Berger W., Prévost M., Pelletier J., Kiss R., Kinzy T. G., Kornienko A., Mathieu V., Targeting of eEF1A with Amaryllidaceae isocarbostyrils as a strategy to combat melanomas. The FASEB Journal 2010 24 11 4575 4584 2-s2.0-78649872112 10.1096/fj.10-162263
36. Zhu G., Yan W., He H. C., Bi X.-C., Han Z.-D., Dai Q.-S., Ye Y.-K., Liang Y.-X., Wang J., Zhong W., Inhibition of proliferation, invasion, and migration of prostate cancer cells by downregulating elongation factor-1 α expression. Molecular Medicine 2009 15 11-12 363 370 2-s2.0-73249145018 10.2119/molmed.2009.00082
37. Edmonds B. T., Wyckoff J., Yeung Y.-G., Wang Y., Stanley E. R., Jones J., Segall J., Condeelis J., Elongation factor-1 α is an overexpressed actin binding protein in metastatic rat mammary adenocarcinoma. Journal of Cell Science 1996 109 11 2705 2714 2-s2.0-0029911314 (Pubitemid 26388355)
38. Anand N., Murthy S., Amann G., Wernick M., Porter L. A., Cukier I. H., Collins C., Gray J. W., Diebold J., Demetrick D. J., Lee J. M., Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer. Nature Genetics 2002 31 3 301 305 2-s2.0-0036635310 10.1038/ng904
39. Edmonds B. T., Murray J., Condeelis J., pH regulation of the F-actin binding properties of Dictyostelium elongation factor 1 α The Journal of Biological Chemistry 1995 270 25 15222 15230 2-s2.0-0029020353 10.1074/jbc.270.25.15222
40. Pecorari L., Marin O., Silvestri C., Candini O., Rossi E., Guerzoni C., Cattelani S., Mariani S. A., Corradini F., Ferrari-Amorotti G., Cortesi L., Bussolari R., Raschellà G., Federico M. R., Calabretta B., Elongation factor 1 alpha interacts with phospho-Akt in breast cancer cells and regulates their proliferation, survival and motility. Molecular Cancer 2009 8 1, article 58 2-s2.0-68949217138
41. Sonenberg N., Translation factors as effectors of cell growth and tumorigenesis. Current Opinion in Cell Biology 1993 5 6 955 960 2-s2.0-0027445185 (Pubitemid 23340500)